1-(3-bromophenyl)-3-(4-(2-(1-methyl-1H-benzo[d]imidazol-2-yl)ethyl)phenyl)urea

ID: ALA4520451

PubChem CID: 46382346

Max Phase: Preclinical

Molecular Formula: C23H21BrN4O

Molecular Weight: 449.35

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cn1c(CCc2ccc(NC(=O)Nc3cccc(Br)c3)cc2)nc2ccccc21

Standard InChI:  InChI=1S/C23H21BrN4O/c1-28-21-8-3-2-7-20(21)27-22(28)14-11-16-9-12-18(13-10-16)25-23(29)26-19-6-4-5-17(24)15-19/h2-10,12-13,15H,11,14H2,1H3,(H2,25,26,29)

Standard InChI Key:  MHCJGKYOXVHJDJ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
    2.4543  -12.6045    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4531  -13.4241    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1612  -13.8330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1594  -12.1957    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8680  -12.6009    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8728  -13.4195    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6528  -13.6680    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.1302  -13.0029    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6451  -12.3435    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.9099  -14.4437    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9474  -12.9980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3518  -12.2879    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1690  -12.2831    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5797  -12.9903    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3961  -12.9858    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8013  -12.2752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3842  -11.5676    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5691  -11.5755    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6185  -12.2693    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.0322  -12.9740    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8494  -12.9681    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.6287  -13.6847    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.2631  -13.6729    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8585  -14.3801    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2715  -15.0844    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0896  -15.0789    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4928  -14.3633    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0775  -13.6620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8677  -15.7948    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
  7 10  1  0
  8 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
 16 19  1  0
 19 20  1  0
 20 21  1  0
 20 22  2  0
 21 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
 25 29  1  0
M  END

Associated Targets(Human)

NTRK2 Tclin Neurotrophic tyrosine kinase receptor type 2 (3279 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NTRK1 Tclin Nerve growth factor receptor Trk-A (7922 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 449.35Molecular Weight (Monoisotopic): 448.0899AlogP: 5.77#Rotatable Bonds: 5
Polar Surface Area: 58.95Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.51CX Basic pKa: 5.82CX LogP: 5.80CX LogD: 5.79
Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.41Np Likeness Score: -1.63

References

1. Subramanian G, Zhu Y, Bowen SJ, Roush N, White JA, Huczek D, Zachary T, Javens C, Williams T, Janssen A, Gonzales A..  (2019)  Lead identification and characterization of hTrkA type 2 inhibitors.,  29  (22): [PMID:31610943] [10.1016/j.bmcl.2019.126680]

Source